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Abstract. In this paper, a new method, based on articial neural networks (ANN),
has been introduced for recognizing pathogenic antibodies in Systemic Lupus Erythmato-
sus (SLE). dsDNA binding antibodies have been implicated in the pathogenesis of this
autoimmune disease. In order to identify these dsDNA binding antibodies, the protein
sequences of 42 dsDNA binding and 608 non-dsDNA binding antibodies were extracted
from Kabat database and coded using ve dierent physicochemical properties of their
amino acids. Coded antibodies were used as the training patterns for ve parallel general
regression neural networks (GRNNs). Comparing the results obtained by the proposed
method with other published results shows the ecacy of proposed approach.
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1. Introduction. Systemic Lupus Erythematosus (SLE or `lupus') is a major autoim-
mune rheumatic disease where autoantibodies are frequently targeted against intracellular
antigens of the cell nucleus (double and single stranded DNA) [1]. Unfortunately, the cause
of lupus is unknown. The Lupus Foundation of America estimates that approximately one
million Americans have SLE [2]. Lupus can occur at any age and in either sex, although
it is more common in women of childbearing ages [3]. SLE can aect almost any organ
or system of the body. In most cases, the disease aects the kidneys, lungs and cen-
tral nervous system. Infection, lupus ares and cardiovascular disease are cause of most
deaths [1,4]. In general, people suering from SLE have periods of illness and wellness
with varying signs. Some have just a few signs of the disease while others have more. This
variation in clinical characteristics has made diagnosis of SLE very challenging. According
to the result of an experiment on more than ve million U.S. Armed Forces personnel, in
115 of the 130 patients with SLE (88 percent), at least one SLE autoantibody tested was
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